Research Catalogue
Peptide Blend
Cagrisema
Compound Overview
Cagrisema is a combination of cagrilintide and semaglutide studied in clinical research for dual amylin/GLP-1 receptor pharmacology.
Storage & Handling
Store at -20°C. Protect from light.
Batch Reference
AU-CAGRIS-2601
Current Lot
Request full batch documentation via the enquiry form or COA button.
Available Specifications
Documentation Requests
Select a specification above, then request documentation.
Quality Standards
✓≥99% Purity — HPLC verified
✓Mass spectrometry identity confirmed
✓Lyophilised — shipped cold-chain
✓COA available for every batch
✓GMP-aligned synthesis process
For laboratory research use only. Not for human consumption, therapeutic, diagnostic, or cosmetic use.